Legal status · United States
Is Tesamorelin / Ipamorelin legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Tesamorelin / Ipamorelin is an approved medicine in the United States, classified as "No approved blend; tesamorelin alone is approved as Egrifta". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 5 human studies are cited on its profile.
Tesamorelin / Ipamorelin in the United States at a glance
| Classification | No approved blend; tesamorelin alone is approved as Egrifta |
|---|---|
| Note | Tesamorelin is FDA-approved for HIV-associated lipodystrophy. The blend is compounded or grey-market and has not been reviewed by the FDA for safety, purity or efficacy. |
| FDA approval status | Not approved as a blend. Tesamorelin alone is FDA-approved as Egrifta for HIV-associated lipodystrophy; ipamorelin is not approved and no combination product exists. |
| Human studies cited | 5 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Tesamorelin / Ipamorelin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Tesamorelin / Ipamorelin for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Tesamorelin / Ipamorelin is
The clinic version of the growth hormone blend, pairing the one GHRH analogue with FDA approval against 806 patients of Phase 3 data with a ghrelin mimetic whose single human trial missed its endpoint. No study has tested the two together. On the common 5 mg plus 5 mg vial, reaching the 2 mg tesamorelin dose that produced the approved result also delivers 2 mg of ipamorelin, roughly seven to ten times the dose ipamorelin is used at alone.
This is the blend that gets prescribed rather than shipped in a plain box, and it is the one where the gap between component evidence and blend evidence is widest. Tesamorelin is a stabilised GHRH analogue approved as Egrifta.
Mechanism: Tesamorelin activates the pituitary GHRH receptor, raising the amplitude of endogenous growth hormone pulses while preserving hypothalamic feedback, which is the property that let it reduce visceral fat without the effects of giving growth hormone directly. Ipamorelin activates the ghrelin receptor GHS-R1a on the same cell, a separate pathway that also releases growth hormone and reduces somatostatin tone.
Regulatory history: Not approved as a blend. Tesamorelin alone is FDA-approved as Egrifta for HIV-associated lipodystrophy; ipamorelin is not approved and no combination product exists.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Tesamorelin / Ipamorelin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Tesamorelin / Ipamorelin in other countries
Frequently asked questions
Is Tesamorelin / Ipamorelin legal in the United States?
Yes. Tesamorelin / Ipamorelin is an approved medicine in the United States, classified as "No approved blend; tesamorelin alone is approved as Egrifta". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 5 human studies are cited on its profile. Note: Tesamorelin is FDA-approved for HIV-associated lipodystrophy. The blend is compounded or grey-market and has not been reviewed by the FDA for safety, purity or efficacy.
Can I buy Tesamorelin / Ipamorelin in the United States?
Only with a prescription. Tesamorelin / Ipamorelin is classified as "No approved blend; tesamorelin alone is approved as Egrifta" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection. Note: Tesamorelin is FDA-approved for HIV-associated lipodystrophy. The blend is compounded or grey-market and has not been reviewed by the FDA for safety, purity or efficacy.
Is Tesamorelin / Ipamorelin FDA approved?
Yes. FDA status: Not approved as a blend. Tesamorelin alone is FDA-approved as Egrifta for HIV-associated lipodystrophy; ipamorelin is not approved and no combination product exists.. Current US classification: "No approved blend; tesamorelin alone is approved as Egrifta". On the evidence, 5 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Tesamorelin / Ipamorelin live on its compound profile.
Tesamorelin / Ipamorelin profileThis page is general information about the regulatory status of Tesamorelin / Ipamorelin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.